Tomomi Egawa-Takata

8PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Preventative health carePacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 07, 2026
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer.

|Oct 20, 2025
VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix.

Mariya Kobayashi, Satoshi Nakagawa, Yusuke Ishii

|Oct 25, 2024
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer.

Mika Okazawa-Sakai, Shunsuke A Sakai, Ichinosuke Hyodo

|Feb 26, 2022
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.

Tomomi Egawa-Takata, Yutaka Ueda, Kimihiko Ito

|Nov 22, 2021
The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study.

Kosuke Hiramatsu, Yutaka Ueda, Asami Yagi

|Jul 31, 2020
A survey of 20-year-old Japanese women: how is their intention to undergo cervical cancer screening associated with their childhood HPV vaccination status?

Reisa Kakubari, Tomomi Egawa-Takata, Yutaka Ueda

Pageof 2

Frequent Collaborators

3 joint publications

Kimihiko Ito

2 joint publications

Masanori Isobe

2 joint publications

Shogen Boku

2 joint publications

Yutaka Ueda